154 related articles for article (PubMed ID: 7392542)
21. Hepatitis B infection in pediatric dialysis and transplant patients: significance of e antigen.
Ettenger RB; Tong MJ; Landing BH; Mosley J; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Jordan SC; Wright H; Fine RN
J Pediatr; 1980 Oct; 97(4):550-3. PubMed ID: 6999141
[TBL] [Abstract][Full Text] [Related]
22. [Antigenic E system in hepatitis B virus-induced infection].
Kalinowska B
Pol Arch Med Wewn; 1978 Jun; 59(6):659-65. PubMed ID: 358161
[No Abstract] [Full Text] [Related]
23. Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum.
Norkrans G; Nordenfelt E; Hermodsson S; Iwarson S
Scand J Infect Dis; 1980; 12(2):159-60. PubMed ID: 7375828
[TBL] [Abstract][Full Text] [Related]
24. [Anti-HBc titer in HBeAg(e-antigen) and anti-HBe(anti-e) positive asymptomatic hepatitis B surface antigen (HBsAG) carriers].
Hess G; Arnold W; Meyer zum Büschenfelde KH; Purcell RH
Verh Dtsch Ges Inn Med; 1978; (84):943-5. PubMed ID: 742155
[No Abstract] [Full Text] [Related]
25. Prevalence of HBeAg, anti-HBe and Dane particle-associated DNA polymerase activity in asymptomatic carriers of HBsAg.
Zanetti A; Ferroni P; Bergamini F; Legnani F
Ric Clin Lab; 1979; 9(1):35-9. PubMed ID: 493812
[TBL] [Abstract][Full Text] [Related]
26. Quantitative correlation between the Dane particle-associated DNA polymerase and the hepatitis B e antigen.
Siegert W; Grunst J; Wilmanns W; Frösner GG; Deinhardt F
Infection; 1979; 7(5):220-2. PubMed ID: 511339
[TBL] [Abstract][Full Text] [Related]
27. [Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].
Gudat F; Bianchi L; Stalder GA; Schmid M
Schweiz Med Wochenschr; 1976 Jun; 106(24):812-24. PubMed ID: 792997
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B e antigen polypeptides isolated from sera of individuals infected with hepatitis B virus: comparison with HBeAg polypeptide derived from Dane particles.
Takahashi K; Imai M; Gotanda T; Sano T; Oinuma A; Mishiro S; Miyakawa Y; Mayumi M
J Gen Virol; 1980 Sep; 50(1):49-57. PubMed ID: 7441214
[TBL] [Abstract][Full Text] [Related]
29. Transmission of hepatitis-B-virus by pleural effusion containing Dane particles.
Hess G; Dienes HP; Hess A; Arnold W; Meyer zum Bäuschenfelde KH
Hepatogastroenterology; 1981 Jun; 28(3):151-4. PubMed ID: 7250895
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and biophysical properties of hepatitis B core particles derived from Dane particles and infected hepatocytes.
Fields HA; Hollinger FB; Desmyter J; Melnick JL; Dreesman GR
Intervirology; 1977; 8(6):336-50. PubMed ID: 893038
[TBL] [Abstract][Full Text] [Related]
31. Electron microscopic studies of Dane particles in hepatocytes with special reference to intracellular development of Dane particles and their relation with HBeAg in serum.
Kamimura T; Yoshikawa A; Ichida F; Sasaki H
Hepatology; 1981; 1(5):392-7. PubMed ID: 7308984
[TBL] [Abstract][Full Text] [Related]
32. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B e antigen and antibody activity in hepatitis B virus infection.
Tiku ML; Makhdoomi GM; Beutner KR; Nath N; Ogra PL
J Pediatr; 1977 Oct; 91(4):540-4. PubMed ID: 908972
[TBL] [Abstract][Full Text] [Related]
34. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
35. Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease.
Andres LL; Sawhney VK; Scullard GH; Smith JL; Merigan TC; Robinson WS; Gregory PB
Hepatology; 1981; 1(6):583-5. PubMed ID: 7308991
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunoassay for hepatitis B 'e' antigen and antibody: correlations with viral replication and prognostic value.
Baraldini M; Facchini A; Miglio F; Ramadori G; Alberti A; Realdi G
Vox Sang; 1981 Sep; 41(3):139-45. PubMed ID: 7331287
[TBL] [Abstract][Full Text] [Related]
37. Morphological irregularities in Dane particle cores.
Stannard LM; Hodgkiss M
J Gen Virol; 1979 Nov; 45(2):509-14. PubMed ID: 541667
[TBL] [Abstract][Full Text] [Related]
38. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
Lyra LG
Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
[TBL] [Abstract][Full Text] [Related]
39. Albumin receptors on HBsAG particles and subsequent sero-conversion designate HBeAG-positive patients among chronic active liver disease patients.
Tsuji T
Acta Med Okayama; 1984 Feb; 38(1):89-92. PubMed ID: 6322527
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.
Krogsgaard K; Wantzin P; Aldershvile J; Kryger P; Andersson P; Nielsen JO
J Infect Dis; 1986 Feb; 153(2):298-303. PubMed ID: 3944482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
